Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
16.43
+0.26 (1.61%)
Oct 29, 2025, 12:51 PM EDT - Market open
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $431.3 million as of October 29, 2025. Its market cap has increased by 121.94% in one year.
Market Cap
431.30M
Enterprise Value
333.35M
1-Year Change
121.94%
Ranking
Category
Stock Price
$16.43
Market Cap Chart
Since June 26, 2014, Benitec Biopharma's market cap has decreased from $2.23B to $431.30M, a decrease of -80.63%. That is a compound annual growth rate of -13.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 424.47M | 44.76% |
| Dec 31, 2024 | 293.22M | 3,429.00% |
| Dec 29, 2023 | 8.31M | 74.68% |
| Dec 30, 2022 | 4.76M | -77.78% |
| Dec 31, 2021 | 21.41M | 61.99% |
| Dec 31, 2020 | 13.22M | -90.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 732.48B |
| Johnson & Johnson | 457.33B |
| AbbVie | 402.68B |
| UnitedHealth Group | 329.93B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 219.23B |